Cargando…
CAR T-Cell-Based gene therapy for cancers: new perspectives, challenges, and clinical developments
Chimeric antigen receptor (CAR)-T cell therapy is a progressive new pillar in immune cell therapy for cancer. It has yielded remarkable clinical responses in patients with B-cell leukemia or lymphoma. Unfortunately, many challenges remain to be addressed to overcome its ineffectiveness in the treatm...
Autores principales: | Jogalekar, Manasi P., Rajendran, Ramya Lakshmi, Khan, Fatima, Dmello, Crismita, Gangadaran, Prakash, Ahn, Byeong-Cheol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355792/ https://www.ncbi.nlm.nih.gov/pubmed/35936003 http://dx.doi.org/10.3389/fimmu.2022.925985 |
Ejemplares similares
-
Noninvasive in vivo cell tracking using molecular imaging: A useful tool for developing mesenchymal stem cell-based cancer treatment
por: Rajendran, Ramya Lakshmi, et al.
Publicado: (2020) -
Tumor microenvironment signaling and therapeutics in cancer progression
por: Goenka, Anshika, et al.
Publicado: (2023) -
An Update on the Effectiveness of Probiotics in the Prevention and Treatment of Cancer
por: Sankarapandian, Vidya, et al.
Publicado: (2022) -
Application of In Vivo Imaging Techniques for Monitoring Natural Killer Cell Migration and Tumor Infiltration
por: Gangadaran, Prakash, et al.
Publicado: (2020) -
Extracellular Vesicle- and Extracellular Vesicle Mimetics-Based Drug Delivery Systems: New Perspectives, Challenges, and Clinical Developments
por: Gangadaran, Prakash, et al.
Publicado: (2020)